Ahmet Ozaktay, MD
Interventional Pain Medicine · Boca Raton, FLNPI 1649381146
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,502 of the $24,865 with a category attached, or 74.4%. 21 manufacturers reported payments, led by Abbott at 37.5% of the total.
Across 531 payments — averaging $46.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Stimwave Technologies Incorporated$6K
- Medtronic$3K
- Biotronik NRO, Inc.$2K
- Boston Scientific$932
- Spinal Simplicity, LLC$860
- plus $3K from 15 others
Across 2 payments — averaging $582.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1K
What the payments were for
- Consulting fees$5,32521%
- Travel & lodging$9804%
- Food & beverage$18,50274%
- Education$580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 275 | $9,316 |
| Stimwave Technologies Incorporated | 16 | $5,582 |
| Medtronic(2 entities) | 82 | $2,837 |
| Biotronik NRO, Inc. | 31 | $1,851 |
| Boston Scientific | 12 | $932 |
| Spinal Simplicity, LLC | 13 | $860 |
| Saluda Medical Americas, Inc. | 10 | $822 |
| Globus Medical | 17 | $795 |
| Curonix LLC | 11 | $349 |
| Collegium Pharmaceutical, Inc. | 24 | $334 |
| Vertos Medical, Inc. | 5 | $326 |
| SPR Therapeutics, Inc | 17 | $323 |
| Nevro Corp. | 8 | $287 |
| Amgen | 2 | $132 |
| Valinor Pharma, LLC | 2 | $28 |
| AbbVie | 1 | $19 |
| Stryker | 1 | $15 |
| Si-bone, Inc. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $12 |
| Protega Pharmaceutials Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$844
- Prospera$840
- HA MINUTEMAN G3-R$705
- Evoke$525
- Senza$405
- ETERNA$331
- GENERAL - THERAPIES$325
- INTELLIS ADAPTIVESTIM$281
- SYNCHROMEDII$278
- mild Device Kit$277
- Intracept$253
- PROCLAIM$210
- Intracept RF Probe$143
- CFNS StimQ Peripheral Nerve StimulatorSystem$129
- SCS FreedonSpinal Cord Stimulator$129
- Vyrsa V1$121
- AIMOVIG$112
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$109
- Evoke SCS$105
How this compares
$24,865 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 40 | $31,738 |
| OxycontinOxycodone Hcl | 21 | $18,596 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 602 | $15,520 |
| NucyntaTapentadol Hcl | 16 | $11,598 |
| Buprenorphine | 36 | $8,323 |
| Fentanyl | 70 | $7,024 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 344 | $6,830 |
| Gabapentin | 260 | $3,259 |
| Morphine Sulfate ErMorphine Sulfate | 77 | $2,891 |
| Oxycodone Hcl | 167 | $2,721 |
| Tizanidine Hcl | 153 | $2,668 |
| Tramadol Hcl | 291 | $2,113 |
| Morphine Sulfate | 61 | $1,758 |
| Pregabalin | 67 | $887 |
| Methadone Hcl | 49 | $836 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta | $334 | $43,33556 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Boca Raton
- Giuseppe PaeseBoca Raton$180K
- Shatabdi PatelBoca Raton$43K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.